(Q39536979)

12 September 2017

title

Comparison of chlorambucil, azathioprine or cyclophosphamide combined with corticosteroids in the treatment of lupus nephritis (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

12 November 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

12 November 2022

1

M. S. Sabbour

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A85455

12 November 2022

author name string

L. M. Osman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A85455

12 November 2022

language of work or name

English

0 references

publication date

1 February 1979

1 reference

full work available at URL

12 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2133.1979.tb05548.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.1979.tb05548.x/fullpdf

12 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

British Journal of Dermatology

12 November 2022

published in

1 reference

12 September 2017

volume

100

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

113-125

1 reference

The clinical course of the proliferative and membranous forms of lupus nephritis.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

Cancer in the immunosuppressed patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

Studies on the anti-inflammatory action of 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

Immunological studies concerning the nephritis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

Resistance of long-lived lymphocytes and plasma cells in rat lymph nodes to treatment with prednisone, cyclophosphamide, 6-mercaptopurine, and actinomycin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

The Relation of Immunoglobulin Class, Pattern of Antinuclear Antibody, and Complement-Fixing Antibodies to DNA in Sera from Patients with Systemic Lupus Erythematosus*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

Cyclophosphamide in lupus nephritis: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

The prognosis of lupus nephritis. Role of clinical-pathologic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

Effect of 6-mercaptopurine on antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.1979.TB05548.X

Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

12 November 2022

Viruses and autoimmunity

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Maximum utilization of the life table method in analyzing survival

12 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months

12 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Treatment of Lupus Nephritis with Prednisone and Combined Prednisone and Azathioprine

12 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine

12 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Azathioprine and prednisone in the treatment of adults with lupus nephritis. Clinical, histological, and immunological changes with therapy

12 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus

12 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

The natural history of systemic lupus erythematosus by prospective analysis

12 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis

12 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Cyclophosphamide in systemic lupus erythematosus

12 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Effect of azathioprine on the chromosome complement of human bone marrow cells

12 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

12 November 2022

26

44

630

Pollack V.E.

1969

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil

12 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Inhibition of the Inductive Phase of Antibody Formation by 6-Mercaptopurine examined by the Transfer of Isolated Cells

12 November 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Immunosuppressive therapy. The relation between clinical response and immunologic competence

12 November 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

Azathioprine in the treatment of systemic lupus erythematosus. A controlled study

12 November 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2133.1979.TB05548.X

12 November 2022

Identifiers

1 reference

release_qiwsfd4wv5avrjgyyrfkx7xh6u

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qiwsfd4wv5avrjgyyrfkx7xh6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference